Sign in
APEX: A Phase II Randomized Clinical Trial Evaluating the Safety andPreliminary Efficacy of X-82 Administered Orally in the Treatment of Exudative AMD
Michael N. Cohen, MD
Updates from the Field
2020
Evaluation of an Automated Severity Score in Retinopathy of Prematurity
J. Peter Campbell, MD, MPH
Annual Meeting Talks
2018
Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema
Thomas A. Ciulla, MD, MBA, FASRS
2017
Category: Pharmacology